News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
482,841 Results
Type
Article (8039)
Company Profile (139)
Press Release (474759)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166745)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52879)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238201)
Policy (17899)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (478)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33158)
ALS (102)
Alzheimer's disease (963)
Antibody-drug conjugate (ADC) (251)
Approvals (10326)
Artificial intelligence (305)
ASCO (159)
Autoimmune disease (194)
Automation (27)
Bankruptcy (262)
Best Places to Work (6960)
BIO (36)
BIOSECURE Act (1)
Biosimilars (101)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (27)
Breast cancer (497)
Cancer (3532)
Cardiovascular disease (212)
Career advice (245)
Career pathing (1)
CAR-T (166)
Celiac Disease (1)
Cell therapy (463)
Cervical cancer (34)
Clinical research (47703)
Collaboration (1193)
Compensation (1375)
Complete response letters (33)
COVID-19 (748)
CRISPR (62)
C-suite (695)
Cystic fibrosis (84)
Data (5462)
Denatured (4)
Depression (101)
Dermatology (58)
Diabetes (332)
Diagnostics (4134)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (144)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (156)
Earnings (72988)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87403)
Executive appointments (675)
FDA (12262)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (16)
Frontotemporal dementia (23)
Funding (885)
Gene editing (123)
Generative AI (9)
Gene therapy (307)
GLP-1 (283)
Government (938)
Grass and pollen (2)
Guidances (278)
Healthcare (9305)
Hematology (94)
HIV (49)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (95)
Immuno-oncology (53)
Indications (148)
Infectious disease (933)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (244)
Interviews (41)
IPO (12377)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (14)
Layoffs (59)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (485)
Lymphoma (240)
Machine learning (27)
Management (3)
Manufacturing (506)
Marketing (6)
MASH (115)
Medical device (8627)
Medtech (8742)
Mergers & acquisitions (14342)
Metabolic disorders (685)
mRNA (50)
Multiple sclerosis (100)
NASH (4)
Neurodegenerative disease (209)
Neuropsychiatric disorders (38)
Neuroscience (1773)
NextGen: Class of 2026 (3150)
Non-profit (840)
Obesity (219)
Opinion (10)
Ovarian cancer (154)
Pain (166)
Pancreatic cancer (189)
Parkinson's disease (195)
Partnered (11)
Patents (454)
Patient recruitment (469)
Peanut (31)
People (41100)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15421)
Phase 2 (21301)
Phase 3 (14346)
Pipeline (6572)
Policy (18)
Postmarket research (1570)
Preclinical (6524)
Press Release (34)
Prostate cancer (185)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (549)
Real estate (3018)
Recruiting (6)
Regulatory (14650)
Reports (16)
Research institute (578)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (97)
Series A (147)
Series B (116)
Service/supplier (4)
Sickle cell disease (61)
Spinal muscular atrophy (86)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (47)
Vaccines (308)
Venture capital (17)
Weight loss (69)
Women's health (73)
Date
Today (58)
Last 7 days (266)
Last 30 days (1114)
Last 365 days (19096)
2026 (10465)
2025 (19251)
2024 (22985)
2023 (26539)
2022 (34594)
2021 (37169)
2020 (33468)
2019 (23258)
2018 (17502)
2017 (18766)
2016 (17920)
2015 (24263)
2014 (21683)
2013 (18135)
2012 (20222)
2011 (20440)
2010 (20332)
Location
Africa (226)
Alabama (68)
Alaska (2)
Arizona (289)
Arkansas (11)
Asia (17825)
Australia (2088)
California (11434)
Canada (3034)
China (496)
Colorado (461)
Connecticut (387)
Delaware (200)
Europe (24555)
Florida (1707)
Georgia (361)
Hawaii (2)
Idaho (46)
Illinois (671)
India (40)
Indiana (307)
Iowa (13)
Japan (383)
Kansas (97)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1143)
Massachusetts (7543)
Michigan (298)
Minnesota (532)
Mississippi (4)
Missouri (76)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2522)
New Mexico (11)
New York (2720)
North Carolina (1221)
North Dakota (4)
Northern California (5683)
Ohio (263)
Oklahoma (14)
Oregon (14)
Pennsylvania (2182)
Puerto Rico (20)
Rhode Island (29)
South America (405)
South Carolina (75)
South Dakota (1)
Southern California (4743)
Tennessee (111)
Texas (1844)
United States (37232)
Utah (340)
Vermont (1)
Virginia (144)
Washington D.C. (38)
Washington State (887)
West Virginia (1)
Wisconsin (71)
482,841 Results for "pellepharm inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
Press Releases
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 2, 2026
·
12 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update
August 19, 2025
·
2 min read
Press Releases
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026
·
17 min read
Biotech Bay
PellePharm to Highlight Clinical Programs at the 29th Congress of the European Academy of Dermatology and Venereology
PellePharm, Inc., a BridgeBio Pharma, Inc. company, today announced the presentation of various data highlighting product candidate patidegib topical gel for adults with Gorlin syndrome and high-frequency basal cell carcinoma (HF-BCC). The presentations will be made during the 29th Congress of the European Academy of Dermatology and Venereology (EADV), to be held virtually October 29 – 31, 2020. Patidegib topical gel
October 29, 2020
·
9 min read
Press Releases
Definium Therapeutics, Inc. Announces Proposed Public Offering
June 23, 2026
·
6 min read
Press Releases
Belmont Medical Completes Acquisition of Arcos, Inc.
June 17, 2026
·
4 min read
Business
LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases
LEO Pharma A/S acquires minority stake in PellePharm and provides additional non-dilutive capital to fund PellePharm development programs; obtains option to acquire all shares in PellePharm
November 20, 2018
·
7 min read
Press Releases
Catheter Precision, Inc. Announces Issuance of Two Key Patents
July 6, 2026
·
4 min read
Drug Development
PellePharm Completes Enrollment of Pivotal Phase 3 Clinical Trial of Patidegib Topical Gel in Patients with Gorlin Syndrome
PellePharm, Inc., a BridgeBio Pharma, Inc. company, announced the completion of enrollment for its pivotal Phase 3 clinical trial of Patidegib Topical Gel 2% vs. vehicle gel in patients with Gorlin Syndrome.
December 2, 2019
·
7 min read
1 of 48,285
Next
